Arab World vs Switzerland: Survival to age 65, male
Arab World
75.8%
in 2024
Switzerland
91.0%
in 2024
Arab World rank
14th
Switzerland rank
13th
Survival to age 65, male over time
- Arab World
- Switzerland
How they compare
Switzerland currently reports 91.0% against 75.8% in Arab World, a difference of 15.2%.
That makes Switzerland's figure about 1.2 times Arab World's.
Across all 65 years both countries report, Switzerland has been ahead every year.
Arab World ranks 14th and Switzerland ranks 13th of 47 groups.
Switzerland has averaged higher in every one of the 7 decades both report.
Head to head by decade
| Decade | Arab World | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 38.1% | 71.3% | 33.2% | Switzerland |
| 1970s | 45.2% | 75.1% | 29.9% | Switzerland |
| 1980s | 53.1% | 78.4% | 25.3% | Switzerland |
| 1990s | 61.9% | 82.0% | 20.2% | Switzerland |
| 2000s | 67.4% | 86.4% | 19.0% | Switzerland |
| 2010s | 72.1% | 89.6% | 17.5% | Switzerland |
| 2020s | 74.1% | 90.6% | 16.5% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, male, Arab World or Switzerland?
- Switzerland, at 91.0% against 75.8% in Arab World as of 2024.
- What is the difference in survival to age 65, male between Arab World and Switzerland?
- 15.2%, with Switzerland ahead.
- How many years of comparable data are there for Arab World and Switzerland?
- 65 years are reported by both, from 1960 to 2024.
- How do Arab World and Switzerland rank globally for survival to age 65, male?
- Arab World ranks 14th and Switzerland ranks 13th of 47 groups.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, male (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.